Smith & Nephew (SN) Competitors

Smith & Nephew (LON:SN) and Haleon (LON:HLN) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, earnings, community ranking, risk, valuation and dividends.

Do analysts rate SN or HLN?

Smith & Nephew presently has a consensus target price of GBX 3,916, suggesting a potential upside of 282.98%. Haleon has a consensus target price of GBX 415, suggesting a potential upside of 10.55%. Given Smith & Nephew's higher probable upside, equities research analysts plainly believe Smith & Nephew is more favorable than Haleon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smith & Nephew	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
Haleon	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has better earnings & valuation, SN or HLN?

Haleon has higher revenue and earnings than Smith & Nephew. Haleon is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smith & Nephew	£5.64B	1.58	£305M	£0.27	3,787.04
Haleon	£11.26B	3.01	£1.09B	£0.12	3,128.33

Which has more risk & volatility, SN or HLN?

Smith & Nephew has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500. Comparatively, Haleon has a beta of 0.19, meaning that its share price is 81% less volatile than the S&P 500.

Does the media prefer SN or HLN?

In the previous week, Haleon had 1 more articles in the media than Smith & Nephew. MarketBeat recorded 2 mentions for Haleon and 1 mentions for Smith & Nephew. Haleon's average media sentiment score of 0.43 beat Smith & Nephew's score of 0.00 indicating that Haleon is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Smith & Nephew	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Haleon	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do insiders & institutionals hold more shares of SN or HLN?

62.2% of Smith & Nephew shares are held by institutional investors. Comparatively, 43.9% of Haleon shares are held by institutional investors. 0.2% of Smith & Nephew shares are held by company insiders. Comparatively, 10.7% of Haleon shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Does the MarketBeat Community believe in SN or HLN?

Smith & Nephew received 549 more outperform votes than Haleon when rated by MarketBeat users. Likewise, 62.02% of users gave Smith & Nephew an outperform vote while only 29.73% of users gave Haleon an outperform vote.

Company	Underperform	Outperform
Smith & Nephew	Outperform Votes 560 62.02%	Underperform Votes 343 37.98%
Haleon	Outperform Votes 11 29.73%	Underperform Votes 26 70.27%

Is SN or HLN more profitable?

Haleon has a net margin of 9.66% compared to Smith & Nephew's net margin of 5.41%. Haleon's return on equity of 6.82% beat Smith & Nephew's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smith & Nephew	5.41%	5.84%	4.51%
Haleon	9.66%	6.82%	4.45%

Is SN or HLN a better dividend stock?

Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 2.8%. Haleon pays an annual dividend of GBX 6 per share and has a dividend yield of 1.6%. Smith & Nephew pays out 10,740.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Haleon pays out 5,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Summary

Smith & Nephew and Haleon tied by winning 10 of the 20 factors compared between the two stocks.